Cancer Research Audrey Hepburn  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koch, C. J.
Right arrow Articles by Evans, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, C. J.
Right arrow Articles by Evans, S. M.
[Cancer Research 62, 3626-3629, July 1, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Radiosensitization of Hypoxic Tumor Cells by Dodecafluoropentane

A Gas-Phase Perfluorochemical Emulsion1

Cameron J. Koch2, Patricia R. Oprysko, A. Lee Shuman, W. Timothy Jenkins, Gordon Brandt3 and Sydney M. Evans

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6072 [C. J. K., P. R. O., A. L. S., W. T. J., S. M. E.], and Sonus Pharmaceuticals, Bothell, Washington 98021 [G. B.]

One method to make hypoxic, radioresistant cells more radiation sensitive has been to increase the oxygen carrying capacity of normal blood using liquid perfluorochemical emulsions combined with breathing high pO2 gases. We investigated the ability of dodecafluoropentane (DDFP) to sensitize the moderately radiation-resistant Morris 7777 hepatoma based on our previous inability to modify the radiation response of this tumor. DDFP is used in very small quantities compared with perfluorchemicals reported previously. Rats under isoflurane anesthesia were administered EF5 3 h before irradiation to monitor the pretreatment level of tissue hypoxia. At -40 min, DDFP was administered i.v. at 3.5 ml/kg over 30 min. At -10 min, the rats were either continued with air (for controls) or switched to carbogen. The tumors were then irradiated and processed for evaluation of radiation response. Tumor-cell survival for DDFP treatment with air-breathing animals was not significantly different from controls treated without DDFP. Carbogen alone provided minimal sensitization. DDFP plus carbogen caused dramatic radiosensitization, and the radiation response of cells from these tumors was the same as a completely aerobic radiation response. DDFP plus carbogen appears to completely reverse the hypoxic cell radioresistance in this tumor model.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. F. Wilson
Quantifying the role of oxygen pressure in tissue function
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H11 - H13.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. F. Wilson, W. M. F. Lee, S. Makonnen, O. Finikova, S. Apreleva, and S. A. Vinogradov
Oxygen pressures in the interstitial space and their relationship to those in the blood plasma in resting skeletal muscle
J Appl Physiol, December 1, 2006; 101(6): 1648 - 1656.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Vordermark, S. M. Evans, S. M. Hahn, K. D. Judy, and C. J. Koch
Significance of Hypoxia in Malignant Glioma. Re: Evans et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 2004;10:8177-84
Clin. Cancer Res., May 15, 2005; 11(10): 3966 - 3968.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Evans, K. D. Judy, I. Dunphy, W. T. Jenkins, W.-T. Hwang, P. T. Nelson, R. A. Lustig, K. Jenkins, D. P. Magarelli, S. M. Hahn, et al.
Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors
Clin. Cancer Res., December 15, 2004; 10(24): 8177 - 8184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.